500,000
Participants
Start Date
April 1, 2025
Primary Completion Date
December 31, 2035
Study Completion Date
December 31, 2035
Blood Draw
Participants will be asked to contribute approximately 36 mL of blood using standard procedures and obtained at the time of a clinically ordered routine blood draw or a study ordered blood draw. Participants may be asked to contribute additional blood samples over the course of their participation in the study.
Tissue Collection
If the participant is undergoing a clinically ordered procedure (e.g. heart surgery/biopsy/transplant), then they will be asked to contribute tissue to the study before any tissue is collected during the procedure. Most samples collected by the HeH BioBank will be tissue that would be normally discarded after the procedure.
DNA Collection
Participants will be asked to contribute their DNA for Whole Genome Sequencing (WGS) to help identify genetic markers of heart disease. DNA will be obtained at the time of the blood draw or obtained through DNA collection kits administered to participants who are unable or unwilling to undergo a blood draw.
Medical Chart Review
Demographic, clinical, and pathologic information will be extracted from the participant's medical record.
University of California, San Francisco, San Francisco
University of California, San Francisco
OTHER